Sanctuary Advisors LLC Acquires Shares of 25,883 Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Sanctuary Advisors LLC bought a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 25,883 shares of the pharmacy operator’s stock, valued at approximately $313,000.

Other large investors have also modified their holdings of the company. Scientech Research LLC purchased a new stake in Walgreens Boots Alliance during the second quarter worth about $1,215,000. Ariel Investments LLC boosted its stake in shares of Walgreens Boots Alliance by 10.8% during the 2nd quarter. Ariel Investments LLC now owns 2,038,878 shares of the pharmacy operator’s stock worth $24,660,000 after acquiring an additional 198,891 shares in the last quarter. Cetera Investment Advisers grew its holdings in shares of Walgreens Boots Alliance by 89.8% in the 1st quarter. Cetera Investment Advisers now owns 349,464 shares of the pharmacy operator’s stock worth $7,580,000 after acquiring an additional 165,389 shares during the period. Norden Group LLC purchased a new position in Walgreens Boots Alliance in the 1st quarter valued at approximately $1,515,000. Finally, SteelPeak Wealth LLC raised its holdings in Walgreens Boots Alliance by 93.3% during the first quarter. SteelPeak Wealth LLC now owns 347,212 shares of the pharmacy operator’s stock worth $7,531,000 after purchasing an additional 167,610 shares during the last quarter. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Price Performance

WBA opened at $10.79 on Friday. Walgreens Boots Alliance, Inc. has a 1 year low of $8.22 and a 1 year high of $27.05. The company’s 50 day simple moving average is $9.41 and its 200 day simple moving average is $13.14. The stock has a market capitalization of $9.31 billion, a PE ratio of -1.60, a P/E/G ratio of 1.06 and a beta of 0.70. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.31 and a current ratio of 0.65.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 3.99% and a positive return on equity of 12.63%. The company had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. During the same quarter last year, the firm posted $0.67 earnings per share. Walgreens Boots Alliance’s revenue was up 5.9% on a year-over-year basis. As a group, sell-side analysts expect that Walgreens Boots Alliance, Inc. will post 2.85 EPS for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on WBA shares. Barclays raised their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a report on Wednesday. UBS Group lifted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the stock a “neutral” rating in a research report on Thursday. Bank of America lowered their target price on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating on the stock in a report on Wednesday, September 4th. JPMorgan Chase & Co. reduced their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating on the stock in a research report on Friday, August 30th. Finally, Evercore ISI increased their price objective on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research note on Wednesday. Four equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Walgreens Boots Alliance presently has a consensus rating of “Hold” and a consensus price target of $13.38.

Get Our Latest Analysis on WBA

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.